Drug provocation tests (DPTs) are also used in some patients with a history of a contrast medium (CM)-hypersensitivity reaction. Since the use of contrast agents requires special knowledge that is present in radiology but not necessarily in allergology, this overview should close the knowledge gaps. The literature, and the package inserts of the industry dealing with DPTs in contrast hypersensitivity reactions was analyzed and the results presented. Historical analyses revealed that provocation tests were already done in the past, and called pre-testing. Due to disadvantages, this diagnostic tool was abandoned. A few years later, DPT was introduced as an innovative diagnostic procedure. The DPT has the 3 main disadvantages: a missing standardization, patients at risk (such as compromised renal function) are rarely taken into account, and a negative DPT does not exclude a subsequent CM reaction. DPTs (formerly called pre-testing) are a well-known method for diagnosing CM-related hypersensitivity reactions. Since the disadvantages of this diagnosis outweigh the advantages, we propose replacing DPT with routine contrast-enhanced imaging examination in radiology.
Keyphrases
- contrast enhanced
- magnetic resonance
- diffusion weighted
- magnetic resonance imaging
- drug induced
- computed tomography
- diffusion weighted imaging
- healthcare
- artificial intelligence
- end stage renal disease
- newly diagnosed
- systematic review
- ejection fraction
- high resolution
- adverse drug
- clinical practice
- patient reported outcomes
- single cell
- peritoneal dialysis
- deep learning
- photodynamic therapy
- electronic health record